Skip to content
10-Q

Quarterly Report

Aevi Genomic Medicine, Inc.

0001144204-19-039522

← back to feed
Filed
Aug 13, 2019 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2019 · Aug 9, 2019 64.77M sh
Operating Cash Flow Q2 2019 · Jun 30, 2019 −$8.64M
Operating Cash Flow Q2 2019 · Jun 30, 2018 −$14.45M
Cash And Equivalents Q2 2019 · Jun 30, 2019 $3.44M
Cash And Equivalents Q2 2019 · Dec 31, 2018 $12.08M
Cash And Equivalents Q2 2019 · Jun 30, 2018 $19.15M
Cash And Equivalents Q2 2019 · Dec 31, 2017 $33.73M
Stockholders Equity Q2 2019 · Jun 30, 2019 $332K
Stockholders Equity Q2 2019 · Mar 31, 2019 $3.72M
Stockholders Equity Q2 2019 · Dec 31, 2018 $7.93M
Stockholders Equity Q2 2019 · Jun 30, 2018 $15.29M
Stockholders Equity Q2 2019 · Mar 31, 2018 $22.7M
Stockholders Equity Q2 2019 · Dec 31, 2017 $30.62M
Current Liabilities Q2 2019 · Jun 30, 2019 $3.69M
Current Liabilities Q2 2019 · Dec 31, 2018 $4.35M
Total Liabilities Q2 2019 · Jun 30, 2019 $3.69M
Total Liabilities Q2 2019 · Dec 31, 2018 $4.35M
Current Assets Q2 2019 · Jun 30, 2019 $4.01M
Current Assets Q2 2019 · Dec 31, 2018 $12.25M
Total Assets Q2 2019 · Jun 30, 2019 $4.02M
Total Assets Q2 2019 · Dec 31, 2018 $12.28M
Sga Expense Q2 2019 · Jun 30, 2019 $1.42M
Sga Expense Q2 2019 · Jun 30, 2019 $3.1M
Sga Expense Q2 2019 · Jun 30, 2018 $2.5M
Sga Expense Q2 2019 · Jun 30, 2018 $4.68M
Net Income Q2 2019 · Jun 30, 2019 −$3.65M
Net Income Q2 2019 · Jun 30, 2019 −$8.48M
Net Income Q2 2019 · Mar 31, 2019 −$4.84M
Net Income Q2 2019 · Jun 30, 2018 −$8.19M
Net Income Q2 2019 · Jun 30, 2018 −$16.9M
Net Income Q2 2019 · Mar 31, 2018 −$8.71M
Operating Income Q2 2019 · Jun 30, 2019 −$3.65M
Operating Income Q2 2019 · Jun 30, 2019 −$8.5M
Operating Income Q2 2019 · Jun 30, 2018 −$8.25M
Operating Income Q2 2019 · Jun 30, 2018 −$16.99M